#CharchaMe | A major step towards making cancer treatment more affordable. The Government has revised the maximum retail prices (MRP) of 543 branded cancer medicines and capped trade margins at 30% for 137 non scheduled cancer drugs. The move is expected to reduce the prices of affected medicines by up to 70%, providing financial relief to cancer patients and their families.